JPWO2021199032A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021199032A5 JPWO2021199032A5 JP2022559816A JP2022559816A JPWO2021199032A5 JP WO2021199032 A5 JPWO2021199032 A5 JP WO2021199032A5 JP 2022559816 A JP2022559816 A JP 2022559816A JP 2022559816 A JP2022559816 A JP 2022559816A JP WO2021199032 A5 JPWO2021199032 A5 JP WO2021199032A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- disorders
- mitochondria
- enriched
- target cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003174P | 2020-03-31 | 2020-03-31 | |
| US63/003,174 | 2020-03-31 | ||
| US202063118569P | 2020-11-25 | 2020-11-25 | |
| US63/118,569 | 2020-11-25 | ||
| PCT/IL2021/050349 WO2021199032A1 (en) | 2020-03-31 | 2021-03-29 | Mitochondrial augmentation therapy |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023519744A JP2023519744A (ja) | 2023-05-12 |
| JPWO2021199032A5 true JPWO2021199032A5 (https=) | 2024-04-09 |
| JP2023519744A5 JP2023519744A5 (https=) | 2024-04-09 |
| JP7825866B2 JP7825866B2 (ja) | 2026-03-09 |
Family
ID=77928517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559816A Active JP7825866B2 (ja) | 2020-03-31 | 2021-03-29 | ミトコンドリア増強療法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230338427A1 (https=) |
| EP (1) | EP4125959A4 (https=) |
| JP (1) | JP7825866B2 (https=) |
| KR (1) | KR20220161326A (https=) |
| CN (1) | CN115427052A (https=) |
| AU (1) | AU2021248780A1 (https=) |
| BR (1) | BR112022019432A2 (https=) |
| CA (1) | CA3173425A1 (https=) |
| CO (1) | CO2022013978A2 (https=) |
| IL (1) | IL296786A (https=) |
| MX (1) | MX2022012233A (https=) |
| WO (1) | WO2021199032A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12329781B2 (en) | 2018-07-22 | 2025-06-17 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of renal diseases |
| JP2021531288A (ja) | 2018-07-22 | 2021-11-18 | ミノヴィア セラピューティクス リミテッド | 眼疾患のミトコンドリア増強療法 |
| WO2020021536A1 (en) | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy for primary mitochondrial diseases |
| JP7524157B2 (ja) | 2018-07-22 | 2024-07-29 | ミノヴィア セラピューティクス リミテッド | 脳疾患のミトコンドリア増強療法 |
| CA3172402A1 (en) | 2020-03-31 | 2021-10-07 | Minovia Therapeutics Ltd. | Mitochondria-enriched genetically engineered cells and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL299482B2 (en) * | 2015-02-26 | 2025-02-01 | Minovia Therapeutics Ltd | Mammalian cells are enriched with active mitochondria |
| US12551504B2 (en) * | 2018-07-22 | 2026-02-17 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of pancreatic diseases |
| WO2020021536A1 (en) * | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy for primary mitochondrial diseases |
| JP7524157B2 (ja) * | 2018-07-22 | 2024-07-29 | ミノヴィア セラピューティクス リミテッド | 脳疾患のミトコンドリア増強療法 |
| JP7458368B2 (ja) * | 2018-07-22 | 2024-03-29 | ミノヴィア セラピューティクス リミテッド | 筋疾患のミトコンドリア増強療法 |
-
2021
- 2021-03-29 WO PCT/IL2021/050349 patent/WO2021199032A1/en not_active Ceased
- 2021-03-29 MX MX2022012233A patent/MX2022012233A/es unknown
- 2021-03-29 AU AU2021248780A patent/AU2021248780A1/en active Pending
- 2021-03-29 JP JP2022559816A patent/JP7825866B2/ja active Active
- 2021-03-29 KR KR1020227033647A patent/KR20220161326A/ko active Pending
- 2021-03-29 IL IL296786A patent/IL296786A/en unknown
- 2021-03-29 CA CA3173425A patent/CA3173425A1/en active Pending
- 2021-03-29 US US17/912,022 patent/US20230338427A1/en active Pending
- 2021-03-29 CN CN202180024268.7A patent/CN115427052A/zh active Pending
- 2021-03-29 EP EP21779142.5A patent/EP4125959A4/en active Pending
- 2021-03-29 BR BR112022019432A patent/BR112022019432A2/pt not_active Application Discontinuation
-
2022
- 2022-09-29 CO CONC2022/0013978A patent/CO2022013978A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12605410B2 (en) | Mitochondria-enriched genetically engineered cells and uses thereof | |
| CN103263439B (zh) | Cd34干细胞相关方法和组合物 | |
| US11951135B2 (en) | Mitochondrial augmentation therapy of muscle diseases | |
| US12551504B2 (en) | Mitochondrial augmentation therapy of pancreatic diseases | |
| BR112021001190A2 (pt) | terapia de reforço mitocondrial para doenças mitocondriais primárias | |
| JP2021532095A (ja) | 肝臓疾患のミトコンドリア増強療法 | |
| JP2021532093A (ja) | 脳疾患のミトコンドリア増強療法 | |
| JP7825866B2 (ja) | ミトコンドリア増強療法 | |
| BR112020023232A2 (pt) | geração de células nk humanas expandidas e primárias de knock-out com o uso de ribonucleoproteínas cas9 | |
| JP2026048752A (ja) | 造血幹細胞を生成するための方法 | |
| KR20210018437A (ko) | 조혈 줄기 세포를 생산하기 위한 방법 | |
| WO2020158924A1 (ja) | 母児間免疫寛容を誘導する方法 | |
| JPWO2021199032A5 (https=) | ||
| KR20230159813A (ko) | 혈액 적합성을 갖는 혈관 내 이식용 세포, 이의 제조방법 및 용도 | |
| JPWO2020021541A5 (https=) | ||
| Kerrigan et al. | Stem cell therapy of gliomas | |
| JPWO2020021539A5 (https=) | ||
| US20240382534A1 (en) | Mitochondrial augmentation therapy for myelodysplastic syndrome | |
| Pedrazzani | MOBILIZATION-BASED CHEMOTHERAPY-FREE ENGRAFTMENT OF GENE EDITED HEMATOPOIETIC STEM CELLS |